IR
IREHF.US Integrated Research Limited
- Market cap
- USD 36.5M
- P/E
- -
- P/B
- 0.54x
- ROE
- 1.2%
- Dividend yield
- 10.47%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is IREHF.US undervalued?
Graham numberThe Graham number of Integrated Research Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Integrated Research Limited fundamental analysis
No fundamental analysis for Integrated Research Limited yet.
Integrated Research Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Integrated Research Limited
Integrated Research Limited engages in the design, development, implementation, and sale of software to monitor the performance of business-critical computing. The company offers Prognosis, an integrated suite of monitoring and management software for operational insight and optimize operation of HP NonStop, distributed system servers, Unified Communications, and payment environments, and business applications. It also provides Iris, a natural language AI; Elevate, a platfor…
Full company profileIntegrated Research Limited financial statements
Integrated Research Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 91.2M | 91.2M | 101M | 111M | 78.5M | 62.9M | 69.8M | 83.3M | 68.3M | 57.6M |
| Gross Profit | 91.2M | 47.0M | 51.0M | 56.4M | 78.5M | 62.9M | 28.9M | 83.3M | 68.3M | 26.8M |
| Operating Income | 26.6M | 13.7M | 16.3M | 32.7M | 9.78M | -7.28M | -1.07M | 25.3M | 13.4M | -1.18M |
| EBITDA | 37.9M | 36.5M | 41.0M | 43.9M | 23.2M | 10.4M | -1.07M | 25.3M | 13.8M | -502K |
| Net Income | 18.5M | 19.2M | 21.9M | 24.1M | 7.94M | 1.55M | -29.2M | 27.1M | 13.4M | 1.21M |
| EPS | 0.11 | 0.11 | 0.13 | 0.14 | 0.05 | 0.01 | -0.17 | 0.15 | 0.07 | 0.01 |
| Balance Sheet | ||||||||||
| Total Assets | 99.6M | 111M | 114M | 141M | 137M | 132M | 90.8M | 114M | 123M | 120M |
| Total Liabilities | 51.0M | 52.7M | 43.7M | 58.7M | 53.3M | 45.1M | 31.0M | 25.8M | 22.4M | 22.1M |
| Shareholders' Equity | 48.5M | 57.8M | 69.8M | 82.5M | 83.3M | 87.1M | 59.9M | 88.4M | 101M | 97.9M |
| Cash & Short-term Investments | 14.1M | 11.2M | 9.32M | 9.74M | 12.1M | 12.3M | 18.6M | 31.9M | 40.6M | 51.6M |
| Total Debt | - | - | - | 11.5M | 13.1M | 4.87M | 3.05M | 1.97M | 1.85M | 1.52M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 26.2M | 21.4M | 21.2M | 24.8M | 21.9M | 18.8M | 16.0M | 13.0M | 8.68M | 16.1M |
| Capital Expenditure | 803K | 1.16M | 1.27M | 15.2M | 12.2M | 11.8M | 7.79M | 48.0K | 497K | 257K |
| Free Cash Flow | 25.4M | 20.3M | 20.0M | 9.55M | 9.67M | 6.97M | 8.20M | 15.2M | 8.18M | 15.8M |
| Ratios | ||||||||||
| ROE | 38.2% | 33.2% | 31.3% | 29.1% | 9.5% | 1.8% | -48.8% | 30.7% | 13.3% | 1.2% |
| ROA | 18.6% | 17.3% | 19.2% | 17.0% | 5.8% | 1.2% | -32.2% | 23.8% | 10.9% | 1.0% |
| Net Profit Margin | 20.3% | 21.0% | 21.7% | 21.7% | 10.1% | 2.5% | -41.9% | 32.6% | 19.6% | 2.1% |
| Debt to Equity | - | - | - | 0.14x | 0.16x | 0.06x | 0.05x | 0.02x | 0.02x | 0.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Integrated Research Limited dividends
- Dividend yield
- 10.47%
- Forward dividend
- 0.02 USD
- Payout ratio
- 293.1%
- Ex-dividend date
- Sep 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 3.54M | 0.02 | 293.1% |
| 2025 | AUD 3.49M | 0.02 | 26.1% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 6.45M | 0.04 | 81.2% |
| 2020 | USD 12.5M | 0.07 | 51.8% |
| 2019 | USD 12.0M | 0.07 | 55.0% |
| 2018 | USD 11.1M | 0.06 | 58.1% |
| 2017 | USD 11.1M | 0.06 | 59.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Integrated Research Limited
- Insiders 47.64%
- Institutions 0.22%
- Public & others 52.14%
- Shares outstanding 182M
- Free float 90.8M
Integrated Research Limited company profile
- Company name
- Integrated Research Limited
- Ticker
- IREHF.US
- Exchange
- USA Stocks
- Sector
- Technology
- Industry
- Software
- Employees
- 138
- Fiscal year end
- June
- Address
- 420 George Street, Sydney, NSW, Australia, 2000
- Phone
- 61 2 9966 1066
- Website
- ir.com
About Integrated Research Limited
Integrated Research Limited engages in the design, development, implementation, and sale of software to monitor the performance of business-critical computing. The company offers Prognosis, an integrated suite of monitoring and management software for operational insight and optimize operation of HP NonStop, distributed system servers, Unified Communications, and payment environments, and business applications. It also provides Iris, a natural language AI; Elevate, a platform delivered as a service; maintenance, SaaS, testing solutions, and professional services. The company serves banks, credit card companies, telecommunications carriers, technology companies, service providers, and manufacturers through direct sales operations and channel-driven distribution networks in the United States, United Kingdom, Germany, Singapore, Australia, and internationally. Integrated Research Limited was incorporated in 1988 and is based in Sydney, Australia.
Integrated Research Limited management
8- Mr. Ian Lowe ASCMCEO, MD & Director · born 1970
- Mr. Christian Shaw CPAChief Financial Officer
- Mr. Michael TomkinsChief Technology Officer
- Ms. Gemma GarkutHead of Communications & IR
- Mr. Marco CantamessiSenior Vice President of Global Sales
- Mr. Geoff SieronSenior Vice President of IR Labs
- Mr. Elie ShuggiChief Product Officer
- Ms. Leanne RalphCompany Secretary